USPTO serial 79154002
GWPHARM
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- FAIRBANKS, RONALD L
- Law office
- TTAB
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GWPHARM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
GB
Salisbury; Wiltshire SP4 OJR, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michelle L. Visser
MICHELLE L VISSER RADER FISHMAN & GRAUER PLLC39533 WOODWARD AVESTE 140BLOOMFIELD HILLS, MI 48304Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 21, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Dec 21, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 20, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 21, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 28, 2016 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 13, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 13, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 13, 2015 | MAB4 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | — |
| Oct 13, 2015 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Oct 13, 2015 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Oct 13, 2015 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Jun 19, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 24, 2015 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 23, 2015 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Mar 20, 2015 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Mar 20, 2015 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Mar 19, 2015 | OPPF | OPPOSITION PAPERS RECEIVED AT TTAB | — |
| Feb 17, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 17, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 14, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 28, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 28, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 28, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 14, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 14, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jan 12, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jan 12, 2015 | ALIE | ASSIGNED TO LIE | — |
| Dec 21, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 25, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 25, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 22, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 22, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 22, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 21, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 8, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 6, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 6, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 5, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 4, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 4, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 30, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |